IDEX Corporation is a global provider of applied solutions across North America, Europe, and Asia, operating within the Industrials sector, specifically in Specialty Industrial Machinery. The company's business is diversified across Fluid & Metering Technologies, Health & Science Technologies, and Fire & Safety/Diversified Products segments, serving a wide array of industrial, life sciences, and safety markets.
In its most recent reported quarters, IDEX has demonstrated a pattern of meeting or exceeding analyst expectations. For Q4 2025, the company reported actual EPS of $2.10 against an estimate of $2.0636 and actual revenue of $899.1 million against an estimate of $891.25 million. This followed Q3 2025 where actual EPS was $2.03 versus an estimate of $1.9303, and Q2 2025 where actual EPS was $2.07 against an estimate of $1.98998. The preceding quarter, Q1 2025, also saw an EPS beat with actuals of $1.75 compared to an estimate of $1.64088. Revenue figures for Q1 2025 were $814.3 million, and for Q2 2025 were $865.4 million, though estimates were not provided for these periods.
Historically, IDEX has shown a consistent ability to surpass earnings per share estimates, having beaten expectations in the last four reported quarters for which data is available (Q2 2025, Q3 2025, Q4 2025, and Q1 2025). While revenue estimates were not consistently provided, the reported revenue figures for Q4 2025 showed a beat against estimates. The company's performance indicates a stable growth trajectory, with recent quarters showing positive EPS results.
Recent news highlights include BMO Capital initiating coverage with a "Market Perform" rating and a $214 price target, citing strong performance in segments like Fluid & Metering Technologies and Health & Science Technologies, supported by demand in water, pharma, and semiconductor markets, as well as contributions from strategic acquisitions. However, concerns remain regarding organic revenue stagnation over the past two years, suggesting a reliance on acquisitions for growth. The company has also scheduled its Q1 2026 earnings call for May 6, 2026.
Looking ahead, investors will be watching for IDEX's ability to drive organic growth and the effectiveness of its capital deployment strategies, including acquisitions and share repurchases. Key will be management's commentary on achieving the growth implied by the new analyst price target and how the company plans to address the historical organic revenue stagnation.
